0001179110-19-006685.txt : 20190524
0001179110-19-006685.hdr.sgml : 20190524
20190524170201
ACCESSION NUMBER: 0001179110-19-006685
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190523
FILED AS OF DATE: 20190524
DATE AS OF CHANGE: 20190524
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Blaser Brian J
CENTRAL INDEX KEY: 0001492289
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-02189
FILM NUMBER: 19855167
MAIL ADDRESS:
STREET 1: 100 ABBOTT PARK ROAD
CITY: ABBOTT PARK
STATE: IL
ZIP: 60064
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ABBOTT LABORATORIES
CENTRAL INDEX KEY: 0000001800
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 360698440
STATE OF INCORPORATION: IL
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 ABBOTT PARK ROAD
CITY: ABBOTT PARK
STATE: IL
ZIP: 60064-3500
BUSINESS PHONE: 2246676100
MAIL ADDRESS:
STREET 1: 100 ABBOTT PARK ROAD
CITY: ABBOTT PARK
STATE: IL
ZIP: 60064-3500
4
1
edgar.xml
FORM 4 -
X0306
4
2019-05-23
0
0000001800
ABBOTT LABORATORIES
ABT
0001492289
Blaser Brian J
100 ABBOTT PARK ROAD
ABBOTT PARK
IL
60064-6400
0
1
0
0
Executive Vice President
Common shares without par value
2019-05-23
4
M
0
165000
34.94
A
295745
D
Common shares without par value
2019-05-23
4
M
0
175164
39.12
A
470909
D
Common shares without par value
2019-05-23
4
M
0
53163
47.00
A
524072
D
Common shares without par value
2019-05-23
4
M
0
56735
38.40
A
580807
D
Common shares without par value
2019-05-23
4
S
0
450062
75.5201
D
130745
D
Option (right to buy)
34.94
2019-05-23
4
M
0
165000
0
D
2016-02-15
2023-02-14
Common shares
165000
0
D
Option (right to buy)
39.12
2019-05-23
4
M
0
175164
0
D
2017-02-21
2024-02-20
Common shares
175164
0
D
Option (right to buy)
47.00
2019-05-23
4
M
0
53163
0
D
2018-02-20
2025-02-19
Common shares
53163
120000
D
Option (right to buy)
38.40
2019-05-23
4
M
0
56735
0
D
2019-02-19
2026-02-18
Common shares
56735
300000
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.50 to $75.70, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.
These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).
Jessica H. Paik, by power of attorney for Brian J. Blaser
2019-05-24